Crescent Biopharma, Inc.
corporate_fare Company Profile
Crescent Biopharma, Inc. (NASDAQ:CBIO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for CBIO at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Resale Prospectus Filed for 19.7M Shares, Representing Over 70% of Outstanding Equity, Creating Significant Market Overhang
- Selling Securityholders Register Resale of 19.7M Shares, Representing Over 70% of Outstanding Stock
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$10.84M
Net Income
-$153.94M
Op. Cash Flow
-$71.53M
Free Cash Flow
-$72.45M
Operating Income
-$152.63M
Cash & Equivalents
$213.19M
Debt / Equity
0.00×
Net Margin
-14.20×
Shares Outstanding
27.56M sh
Source: 10-K · filed 2026-02-26 · accession 0001628280-26-011983
show_chartPrice Chart
Loading chart...